LALUCA - Landsteiner Lung Cancer Research Platform: Data Update from a Prospective Lung Cancer Registry

被引：0
|
作者：
Rodriguez, V. M. [1 ]
Rosenthaler, D. [1 ]
Fabikan, H. [1 ]
Weinlinger, C. [1 ]
Hochmair, M. J. [1 ]
Illini, O. [1 ]
Krenbek, D. [2 ]
Kirchbacher, K. [3 ]
Mueser, N. [3 ]
Funk, G. -C. [3 ]
Valipour, A. [1 ]
机构：
[1] Karl Landsteiner Inst Lung Res & Pulm Oncol, Dept Resp & Crit Care Med, Klin Floridsdorf, Vienna, Austria
[2] Inst Pathol & Bacteriol, Klin Floridsdorf, Vienna, Austria
[3] Karl Landsteiner Inst Lung Res & Pulm Oncol, Dept Med 2, Klin Ottakring, Vienna, Austria
来源：
WIENER KLINISCHE WOCHENSCHRIFT | 2023年 / 135卷 / 19-20期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P49
引用
收藏
页码：579 / 579
页数：1
相关论文
共 50 条
  • [1] The Landsteiner lung cancer research platform (LALUCA)
    Lang-Stoeberl, Anna
    Fabikan, Hannah
    Hochmair, Maximilan
    Kirchbacher, Klaus
    Rodriguez, Vikaela Mania
    Ay, Leya
    Weinlinger, Christoph
    Rosenthaler, David
    Illini, Oliver
    Mueser, Nino
    Funk, Georg-Christian
    Valipour, Arschang
    WIENER KLINISCHE WOCHENSCHRIFT, 2024,
  • [2] Real-world NGS testing results and treatment modalities in lung cancer: Data update from LALUCA - Landsteiner Lung Cancer Research Platform
    Lang-Stoeberl, Anna
    Rodriguez, Vania Mikaela
    Rosenthaler, David
    Fabikan, Hannah
    Weinlinger, Christoph
    Hochmair, Maximilian
    Illini, Oliver
    Krenbek, Dagmar
    Kirchbacher, Klaus
    Mueser, Nino
    Funk, Georg-Christian
    Valipour, Arschang
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [3] The Landsteiner lung cancer research platform (LALUCA): Objectives, methodology and implementation of a real-world clinical lung cancer registry
    Lang-Stöberl A.
    Fabikan H.
    Hochmair M.
    Kirchbacher K.
    Rodriguez V.M.
    Ay L.
    Weinlinger C.
    Rosenthaler D.
    Illini O.
    Müser N.
    Funk G.-C.
    Valipour A.
    Wiener klinische Wochenschrift, 2025, 137 (7) : 197 - 204
  • [4] Baseline predictors of survival in lung cancer patients: data from the LALUCA real-world registry
    Klemm, T.
    Lang-Stoeberl, A.
    Fabikan, H.
    Rodriguez, V. M.
    Weinlinger, C.
    Hochmair, M.
    Illini, O.
    Ay, L.
    Funk, G. -C.
    Mueser, N.
    Kirchbacher, K.
    Valipour, A.
    WIENER KLINISCHE WOCHENSCHRIFT, 2024, 136 : S541 - S542
  • [5] Real-world quality of lung cancer care in the LALUCA registry
    Pertl, Alexander
    Fabikan, Hannah
    Hochmair, Maximilian
    Illini, Oliver
    Kirchbacher, Klaus
    Robinson, Irina
    Rodriguez, Vania Mikaela
    Weinlinger, Christoph
    Valipour, Arschang
    Funk, Georg-Christian
    WIENER KLINISCHE WOCHENSCHRIFT, 2022, 134 (19-20) : 741 - 741
  • [6] Lung cancer screening rates: Data from the lung cancer screening registry
    Danh Pham
    Bhandari, Shruti
    Oechsli, Malgorzata
    Pinkston, Christina M.
    Kloecker, Goetz H.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [7] Translational research for lung cancer - An update
    Nishio, K
    Korfee, S
    Eberhardt, W
    Saijo, N
    Tamura, T
    PROCEEDINGS OF THE 9TH CENTRAL EUROPEAN LUNG CANCER CONFERENCE, 2004, : 45 - 47
  • [8] SCOT REGISTRY: SMALL CELL LUNG CANCER TREATMENT PROSPECTIVE REGISTRY: INTERIM DATA
    Postmus, P. E.
    Nachbaur, G.
    Namir, N.
    Mehmud, F.
    ANNALS OF ONCOLOGY, 2010, 21 : 150 - 150
  • [9] Prognosis of lung cancer patients in Japan according to data from the Japanese Joint Committee of Lung Cancer Registry
    Sawabata, Noriyoshi
    RESPIRATORY INVESTIGATION, 2014, 52 (06) : 317 - 321
  • [10] Lung Cancer in Non-smokers in Czech Republic: Data from LUCAS Lung Cancer Clinical Registry
    Venclicek, Ondrej
    Skrickova, Jana
    Brat, Kristian
    Fischer, Ondrej
    Havel, Libor
    Hrnciarik, Michal
    Marel, Miloslav
    Opalka, Petr
    Krakorova, Gabriela
    Rozsivalova, Denisa
    Kultan, Juraj
    Mullerova, Andrea
    Zarnayova, Lydia
    Smickova, Petra
    Vasakova, Martina
    Gyorfy, Zsuzsanna
    Jirousek, Michal
    Krejci, Daniel
    Krejci, Jana
    Zuna, Petr
    Svaton, Martin
    Hrda, Kristyna
    Duba, Jaroslav
    Alahakoon, Jana
    Svoboda, Michal
    Silar, Jiri
    ANTICANCER RESEARCH, 2021, 41 (11) : 5549 - 5556
12345